Close Menu

NEW YORK (GenomeWeb) – Foundation Medicine reported after the close of the market on Wednesday that it doubled its revenues in the first quarter, driven by strong growth in its molecular information services to biopharmaceutical companies.

For the three months ended March 31, the Cambridge, Massachusetts-based firm reported $52.8 million in revenues, up from $26.3 million during the same period last year and beating the average Wall Street revenue estimate of $44.9 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.